MiNK Therapeutics
INKT
12 hedge funds and large institutions have $1.15M invested in MiNK Therapeutics in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 4 closing their positions.
0.01% less ownership
Funds ownership: 0.19% → 0.18% (-0.01%)
20% less funds holding
Funds holding: 15 → 12 (-3)
30% less capital invested
Capital invested by funds: $1.65M → $1.15M (-$497K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$22.3K |
| 2 |
BlackRock
New York
|
+$779 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JMPWA
JP Morgan Private Wealth Advisors
San Francisco,
California
|
-$43.5K |
| 2 |
Millennium Management
New York
|
-$28K |
| 3 |
FWA
Freedom Wealth Alliance
Brookfield,
Wisconsin
|
-$8.66K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.41K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$260 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AG
1
Artal Group
Luxembourg
| $549K | – | – | – |
|
|
LF
2
Longbow Finance
Lutry,
Switzerland
| $316K | – | – | – |
|
3
Vanguard Group
Malvern,
Pennsylvania
| $93.1K | – | – | – |
|
|
JMPWA
4
JP Morgan Private Wealth Advisors
San Francisco,
California
| $61.4K | -$43.5K | -2,010 | -38% |
|
5
Geode Capital Management
Boston,
Massachusetts
| $48.6K | – | – | – |
|
6
State Street
Boston,
Massachusetts
| $21.3K | – | – | – |
|
|
7
BlackRock
New York
| $20.6K | +$779 | +36 | +3% |
|
|
8
Renaissance Technologies
New York
| $20K | +$22.3K | +1,030 | New |
|
9
HighTower Advisors
Chicago,
Illinois
| $18K | – | – | – |
|
|
10
UBS Group
Zurich,
Switzerland
| $3.51K | -$1.41K | -65 | -26% |
|
11
Wells Fargo
San Francisco,
California
| $63 | – | – | – |
|
|
12
Millennium Management
New York
| – | -$28K | -1,088 | Closed |
|
|
FWA
13
Freedom Wealth Alliance
Brookfield,
Wisconsin
| – | -$8.66K | -332 | Closed |
|
|
14
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$260 | -12 | -52% |
|
15
Morgan Stanley
New York
| – | -$107 | -4 | Closed |
|
16
Bank of America
Charlotte,
North Carolina
| – | -$26 | -1 | Closed |
|
INKT Hedge Fund Activity: Q1 2023 in Review
12 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in MiNK Therapeutics (INKT) for Q1 2023, worth a combined $1.15M — down 30% from $1.65M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of INKT and 1 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 1 added.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $22.3K. The largest seller was JP Morgan Private Wealth Advisors, cutting an estimated $43.5K.
- 12 institutional investors held MiNK Therapeutics (INKT) as of Q1 2023, down from 15 in Q4 2022.
- Funds reported $1.15M of MiNK Therapeutics stock for Q1 2023, down 30% quarter-over-quarter.
- 1 fund opened new MiNK Therapeutics positions in Q1 2023 and 4 closed out, a net change of -3 holders.
- The largest MiNK Therapeutics buyer in Q1 2023 was Renaissance Technologies, an estimated $22.3K added.
- The largest MiNK Therapeutics seller in Q1 2023 was JP Morgan Private Wealth Advisors, an estimated $43.5K sold.
Based on aggregated 13F filings for Q1 2023.